EXOZYMES INC. financial data

Symbol
EXOZ on Nasdaq
Location
Monrovia, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 638 %
Debt-to-equity 31.47 %
Return On Equity -105 % -1.4%
Return On Assets -79.51 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8,387,250 shares +34.1%
Common Stock, Shares, Outstanding 8,387,250 shares +34.1%
Common Stock, Value, Issued 8 USD +33.3%
Weighted Average Number of Shares Outstanding, Basic 8,387,250 shares +34.1%
Weighted Average Number of Shares Outstanding, Diluted 8,387,250 shares +34.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 3,225,071 USD +68.2%
General and Administrative Expense 5,779,227 USD +47%
Operating Income (Loss) -9,004,298 USD -56.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8,341,816 USD -38.1%
Net Income (Loss) Attributable to Parent -8,339,672 USD -62.8%
Earnings Per Share, Basic -1 USD/shares 0%
Earnings Per Share, Diluted -1 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5,098,687 USD +20.8%
Assets, Current 5,606,050 USD +2.9%
Property, Plant and Equipment, Net 763,012 USD +3.2%
Operating Lease, Right-of-Use Asset 1,124,925 USD -19.5%
Assets 7,719,049 USD +1.2%
Accounts Payable, Current 904,353 USD -0.47%
Liabilities, Current 1,238,362 USD -78.7%
Operating Lease, Liability, Noncurrent 926,587 USD -24.2%
Liabilities 2,344,627 USD -67.3%
Retained Earnings (Accumulated Deficit) -18,449,656 USD -82.5%
Stockholders' Equity Attributable to Parent 5,374,422 USD
Liabilities and Equity 7,719,049 USD +1.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1,133,533 USD -5%
Net Cash Provided by (Used in) Financing Activities -43,254 USD +52.7%
Net Cash Provided by (Used in) Investing Activities -31,046 USD +78.2%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 8,387,250 shares +34.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1,207,833 USD -26.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5,098,687 USD +20.8%
Deferred Tax Assets, Valuation Allowance 3,065,959 USD +59.2%
Operating Lease, Liability 1,200,888 USD -17%
Depreciation 70,503 USD +12.3%
Payments to Acquire Property, Plant, and Equipment 31,046 USD -79.1%
Lessee, Operating Lease, Liability, to be Paid 1,386,765 USD -20%
Property, Plant and Equipment, Gross 1,706,075 USD +21.8%
Operating Lease, Liability, Current 274,301 USD +22.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 368,250 USD +2.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 358,428 USD +2.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 185,877 USD -35.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 378,576 USD +2.8%
Deferred Tax Assets, Operating Loss Carryforwards 1,306,652 USD +1.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 378,576 USD
Operating Lease, Payments 86,319 USD
Additional Paid in Capital 23,824,070 USD +2.7%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 481,750 USD -10.6%
Interest Expense 44,647 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%